Literature DB >> 2268348

Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators.

M Cherkaoui Malki1, Y C Lone, M Corral-Debrinski, N Latruffe.   

Abstract

After experimental treatment of rats with clofibrate or ciprofibrate, two peroxisomes proliferators with hypolipidemic activity, RNAs were prepared from liver, kidney, heart and brain; hybridization was done with DNA probes for c-myc and c-Ha-ras oncogenes and for cyanide insensitive Acyl CoA oxidase, a peroxisomal protein. c-myc mRNA is highly abundant in liver and at a lower extent in kidney, especially after treatment with ciprofibrate; clofibrate also allows a c-myc mRNA increase, but at a lower extent. c-Ha-ras, which is already expressed in all tested tissues from control animals, is stimulated by clofibrate and ciprofibrate treatments. Comparatively these compounds stimulate the cyanide insensitive Acyl CoA oxidase expression as well as they increase the somatic index of liver and kidney. From these experiments we suggest that hepatocarcinogenesis triggered by some hypolipidemic agents could be mediated by proto-oncogene mRNA level increase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268348     DOI: 10.1016/s0006-291x(05)80865-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver.

Authors:  S Bonilla; A Redonnet; C Noël-Suberville; R Groubet; V Pallet; P Higueret
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

2.  Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.

Authors:  Yatrik M Shah; Keiichirou Morimura; Qian Yang; Tomotaka Tanabe; Mitsuhiro Takagi; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

Review 3.  Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

Authors:  R L Melnick
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.